In this paper, we show that abnormal expression of SUPYN is directly involved in immature placental formation in Down syndrome and that maternal serum SUPYN measurement may represent an additional or alternative marker protein for predicting fetal disease. This evidence concerns the gene ERVH48-1 and Down syndrome.